Franklin Genomic Advancements ETF Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Franklin Genomic Advancements ETF price down 0% on Friday
(Updated on May 17, 2024)
No changes to the price of Franklin Genomic Advancements ETF on the last trading day (Friday, 17th May 2024). During the last trading day the ETF fluctuated 0% from a day low at $32.03 to a day high of $32.03. The price has risen in 5 of the last 10 days and is up by 3.45% over the past 2 weeks.
The ETFhas broken the wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $32.00, a level that may pose a second chance to hit a runner. According to fan-theory $35.23 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
HELX Signals & Forecast
The Franklin Genomic Advancements ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $31.65 and $31.17. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, May 16, 2024, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.
A sell signal from a double top formation was found on Monday, March 25, 2024 and based on theory for this formation the price should fall by -2.35% to $31.28 within 13 trading days since signal was issued (Monday, May 20, 2024).
Support, Risk & Stop-loss for Franklin Genomic Advancements ETF
Franklin Genomic Advancements finds support from accumulated volume at $31.54 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the ETF tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the ETF During the last day, the ETF moved $0 between high and low, or 0%. For the last week the ETF has had daily average volatility of 0.151%
The Franklin Genomic Advancements ETF is extremely overbought on RSI14 (84). Normally this may pose a good selling opportunity but since the ETF has broken the trend up, the chance for a major correction due to high RSI is very small as the ETF will find support at the trend broken.
Our recommended stop-loss: $30.97 (-3.32%) (This ETF has low daily movements and this gives low risk. The RSI14 is 84 and this increases the risk substantially. There is a sell signal from a pivot top found 1 day ago.)
Trading Expectations (HELX) For The Upcoming Trading Day Of Monday 20th
For the upcoming trading day on Monday, 20th we expect Franklin Genomic Advancements ETF to open at $32.03, and during the day (based on 14 day Average True Range), to move between $31.81 and $32.24, which gives a possible trading interval of +/-$0.216 (+/-0.67%) up or down from last closing price. If Franklin Genomic Advancements ETF takes out the full calculated possible swing range there will be an estimated 1.35% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $31.54 (1.54%) than the resistance at $32.56 (1.64%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Franklin Genomic Advancements ETF ETF A Buy?
Franklin Genomic Advancements holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score: 0.000 Hold/Accumulate Unchanged
Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.
Predicted Opening Price for Franklin Genomic Advancements ETF of Monday, May 20, 2024
| Fair opening price May 20, 2024 | Current price |
|---|---|
| $32.03 ( 0%) | $32.03 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for HELX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 32.03 | . | |
| R2 | 32.03 | . | ||
| R1 | 32.03 | . | ||
| Current price: | 32.03 | |||
| Support | S1 | 32.03 | . | |
| S2 | 32.03 | . | ||
| S3 | 32.03 | . |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 32.74 | 2.23 % | |
| R2 | 32.58 | 1.72 % | ||
| R1 | 32.56 | 1.64 % | ||
| Current price | 32.03 | |||
| Support | S1 | 31.54 | -1.54% | |
| S2 | 31.05 | -3.06% | ||
| S3 | 30.18 | -5.77% |
HELX Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Dec 29, 2021 | Dec 30, 2021 | Jan 07, 2022 | $0.0040 | 0.0094% |
| 2 | Dec 10, 2021 | Dec 13, 2021 | Dec 21, 2021 | $0.114 | 0.238% |
| 3 | Dec 11, 2020 | Dec 14, 2020 | Dec 23, 2020 | $0.0520 | 0.111% |
FAQ
Click here for our free guide on how to buy Franklin Genomic Advancements ETF ETF.
